Murine regulatory T cells utilize granzyme B to promote tumor metastasis
Cancer Immunology, Immunotherapy · 2023-09 · 72 (9) · 2927-2937
DOI: 10.1007/s00262-023-03410-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, online erschienen am 24.02.2023. Verfasst von Ellis Tibbs und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, University of Maryland Baltimore, School of Medicine, Baltimore, MD, 21201, USA. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, T-Lymphocytes, Cytotoxic. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NCI NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
Regulatory T cells (Tregs) possess a wide range of mechanisms for immune suppression. Among them, Granzyme B (GzmB) and perforin expressed by Tregs were shown to inhibit tumor clearance in previous reports, which contradicted the canonical roles of these cytotoxic molecules expressed by cytotoxic T cells and NK cells in antitumor immune responses. Given the ability of the tumor to manipulate the microenvironment, Treg-derived GzmB function may represent an important approach to aid in tumor growth as well as facilitating tumor metastasis. In this study, we utilized Treg-specific GzmB knockout (Foxp3creGzmBfl/fl) mice to test whether Treg-derived GzmB can aid in tumor progression and metastasis. Using an IL-2 complex to activate GzmB expression in the non-immunogenic B16-F10 tumor model, we provide evidence to show that GzmB produced by Tregs is important for spontaneous metastasis to the lungs. In addition, we depleted CD8 + T cells to selectively measure the impact of Treg-derived GzmB in an experimental lung metastasis model by intravenous injection of B16-F10 tumor cells; our results demonstrate that Treg-derived GzmB plays an important role in increasing the metastatic burden to the lungs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, University of Maryland Baltimore, School of Medicine, Baltimore, MD, 21201, USA.
- Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland Baltimore, Baltimore, USA.
- Department of Microbiology and Immunology, University of Maryland Baltimore, School of Medicine, Baltimore, MD, 21201, USA. XuefangCao@som.umaryland.edu.
- Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland Baltimore, Baltimore, USA. XuefangCao@som.umaryland.edu.
Förderung
- NHLBI NIH HHS
- NCI NIH HHS
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
- National Cancer Institute
Zitieren
APA
Tibbs, E., Kandy, R. R. K., Jiao, D., Wu, L., & Cao, X. (2023). Murine regulatory T cells utilize granzyme B to promote tumor metastasis. Cancer Immunology, Immunotherapy, 72(9), 2927-2937. https://doi.org/10.1007/s00262-023-03410-w
Vancouver
Tibbs E, Kandy RRK, Jiao D, Wu L, Cao X. Murine regulatory T cells utilize granzyme B to promote tumor metastasis. Cancer Immunology, Immunotherapy. 2023;72(9):2927-2937. doi:10.1007/s00262-023-03410-w
BibTeX
@article{Tibbs2023,
author = {Tibbs, Ellis and Kandy, Rakhee Rathnam Kalari and Jiao, Delong and Wu, Long and Cao, Xuefang},
title = {Murine regulatory T cells utilize granzyme B to promote tumor metastasis},
journal = {Cancer Immunology, Immunotherapy},
year = {2023},
volume = {72},
number = {9},
pages = {2927--2937},
doi = {10.1007/s00262-023-03410-w}
}
EUVIMED